Mosaic Immunoengineering (CPMV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 05-2010 | 05-2009 | 05-2008 | 05-2007 | 05-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,361 | 6,259 | 6,475 | 21,708 | 4,085 |
| Marketable Securities | 12 | 58 | 298 | 4,349 | 3,519 |
| Receivables | 157 | 174 | 546 | 352 | 4 |
| Inventories | 137 | 27 | 388 | 46 | N/A |
| Income taxes - deferred | 473 | 286 | 1,391 | 2,440 | N/A |
| Other current assets | 1,117 | 448 | 450 | 0 | 0 |
| TOTAL | $13,417 | $8,065 | $9,851 | $31,399 | $8,015 |
| Non-Current Assets | |||||
| PPE Net | 37 | 86 | 69 | 86 | 64 |
| Investments And Advances | 5,642 | 15,139 | 15,441 | 2,884 | 3,953 |
| Intangibles | 2,365 | 7,543 | 63 | 38 | 32 |
| Other Non-Current Assets | 5,955 | 2,895 | 8 | 8 | 8 |
| TOTAL | $13,999 | $25,662 | $15,581 | $3,016 | $4,057 |
| Total Assets | $27,416 | $33,727 | $25,432 | $34,415 | $12,072 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 494 | 415 | 556 | 934 | 695 |
| Accrued Expenses | 292 | 593 | 374 | 1,087 | 549 |
| TOTAL | $942 | $1,035 | $930 | $2,021 | $1,244 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,122 | 3,042 | N/A | N/A | N/A |
| Deferred Revenues | 156 | 26 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | -231 | 0 | 0 | 0 |
| TOTAL | $3,122 | $3,042 | $1,201 | $12,223 | $N/A |
| Total Liabilities | $4,064 | $4,076 | $2,130 | $14,244 | $1,244 |
| Shareholders' Equity | |||||
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -39,562 | -32,882 | -33,763 | -43,152 | -58,728 |
| Other shareholders' equity | -332 | -480 | 56 | 168 | 0 |
| TOTAL | $23,352 | $29,651 | $23,302 | $20,171 | $10,828 |
| Total Liabilities And Equity | $27,416 | $33,727 | $25,432 | $34,415 | $12,072 |